Difficulty: Medium
Average Score: 90%
Practice
A patient with peptic ulcers report pain in the stomach. A gastric tissue biopsy reveals the presence of Helicobacter pylori infection. What should be the first-line treatment for the patient?
Correct answer
B
Rationale
In treating peptic ulcers caused by Helicobacter pylori infection, the first-line treatment should include a proton pump inhibitor (PPI) and two antibiotics for eradication. Option B) Omeprazole combined with metronidazole and clarithromycin is the correct choice. Omeprazole is a PPI that reduces stomach acid production, creating an optimal environment for antibiotics to work effectively. Metronidazole and clarithromycin are antibiotics commonly used to eradicate H. pylori.
Option A) is incorrect because ketoconazole is an antifungal medication and not typically used in H. pylori treatment. Option C) includes sucralfate, which is not part of the standard H. pylori treatment regimen. Option D) combines omeprazole with clarithromycin and sucralfate, omitting metronidazole, which is essential for H. pylori eradication.
Educationally, understanding the rationale behind H. pylori treatment is crucial for healthcare providers to effectively manage patients with peptic ulcers. Knowledge of appropriate medication combinations based on evidence-based guidelines ensures optimal patient outcomes and prevents antibiotic resistance. It also highlights the importance of individualizing treatment based on microbial sensitivity and patient factors.
Option A) is incorrect because ketoconazole is an antifungal medication and not typically used in H. pylori treatment. Option C) includes sucralfate, which is not part of the standard H. pylori treatment regimen. Option D) combines omeprazole with clarithromycin and sucralfate, omitting metronidazole, which is essential for H. pylori eradication.
Educationally, understanding the rationale behind H. pylori treatment is crucial for healthcare providers to effectively manage patients with peptic ulcers. Knowledge of appropriate medication combinations based on evidence-based guidelines ensures optimal patient outcomes and prevents antibiotic resistance. It also highlights the importance of individualizing treatment based on microbial sensitivity and patient factors.